Our Mission

The American Migraine Foundation (AMF) is a non-profit organization dedicated to the advancement of research and awareness surrounding migraine, a disabling condition that impacts over 36 million men, women and children in the United States. The AMF was founded in 2010 by the American Headache Society to provide access to information and resources for individuals with migraine as well as their family and friends.

Working alongside the American Headache Society, the AMF’s mission is to mobilize a community for patient support and advocacy, as well as drive and support impactful research that translates into treatment advances for patients with migraine and other disabling diseases that cause severe head pain.

Our Core Beliefs

Migraine is more than just a headache, it is a major disabling neurological disease

Public funding for migraine research is disproportionate

Research and awareness are the answers

We must reduce stigma of migraine

We must promote better and earlier diagnosis and treatment

We must minimize the barriers to expert care and innovative disease-specific treatments

Advisory Board

Meet Our Chairman of the Board: David W. Dodick, MD

Dr. David Dodick is a Professor of Neurology at the Mayo Clinic College of Medicine and a consultant in neurology at the Mayo Clinic in Scottsdale, Arizona, as well as the Past-President of the American Headache Society. He is the Program Director of the Mayo Clinic Neurology Residency Program and Headache Medicine Fellowship Program, and the Director of the Headache Program and the Sports Neurology and Concussion Program at Mayo Clinic in Arizona.

In addition, he is an Adjunct Professor and International Chair of Headache in the Department of Neurosciences, Norwegian University of Science and Technology. Dr. Dodick is also President of the International Headache Society, Chair of the American Migraine Foundation.

Dr. Barry Baumel

Barry Baumel

  • MD
  • Department of Neurology, University of Miami School of Medicine
  • Member

Andrew C. Charles

  • MD, FAHS
  • UCLA
Dr. Kathleen B. Digre

Kathleen B. Digre

  • MD, FAHS
  • University of Utah
  • Director, Headache Clinic
Paula Dumas

Paula Dumas

  • Migraine Again
  • CEO and Managing Editor
Dr. Peter Goadsby

Peter J. Goadsby

  • MD, PhD, FAHS
  • University of California, San Francisco
  • Headache Group
Rachel Irwin Koh

Rachel Irwin Koh

  • Franklin W. Olin Graduate School of Business
  • Patient Advocate

Nim Lalvani

  • MPH
  • American Migraine Foundation
  • Director
Deborah Henscheid Lorenz

Deborah Hensheid Lorenz

  • Patient Advocate
Lisa Jacobson

Lisa Jacobson

  • The Daily Migraine

Linda McGillicuddy

  • American Headache Society
  • Chief Executive Officer
Dr. Lawrence Newman

Lawrence C. Newman

  • MD, FAHS
  • NYU Langone Medical Center
  • Director, Division of Headache
Dr. Allan Purdy

R. Allan Purdy

  • MD, FAHS
  • Dalhousie University
  • Professor, Department of Medicine
Robert Shapiro, M.D.

Robert E. Shapiro

  • MD, PhD
  • Departmentof Neurological Sciences University of Vermont College of Medicine
Ken Shubin Stein

Ken Shubin Stein

  • Spencer Capital
  • Chairman and CEO

Corporate Roundtable

The American Headache Society® and American Migraine Foundation would like to thank our Corporate Roundtable sponsors for their continued support.

American Headache Society Platinum Corporate Roundable Sponsor

  • Alder BioPharmaceuticals, Inc.
  • Allergan, Inc.
  • Amgen Novartis
  • Eli Lilly and Company
  • Promius Pharma
  • Teva Pharmaceuticals, Inc.

American Headache Society Gold Corporate Roundable Sponsor

  • Avanir Pharmaceuticals, Inc.
  • eNeura, Inc.
  • Upsher-Smith Laboratories, Inc.

American Headache Society Silver Corporate Roundable Sponsor

  • Pernix Therapeutics